NASDAQ:MPLT

Maplight Therapeutics Stock Forecast

etoro logo Buy MPLT
*Your capital is at risk
$28.82
-0.390 (-1.34%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of MPLT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MPLT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Weaker technical forecast for Maplight Therapeutics, Inc. as stock downgraded to Sell Candidate
(Updated on Jun 18, 2026)

Sell candidate since Jun 18, 2026

The Maplight Therapeutics, Inc. stock price fell by -1.34% on the last day (Thursday, 18th Jun 2026) from $29.21 to $28.82. During the last trading day the stock fluctuated 6.07% from a day low at $28.67 to a day high of $30.41. The price has fallen in 6 of the last 10 days and is down by -4.25% for this period. Volume has increased on the last day by 573 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 981 thousand shares were bought and sold for approximately $28.27 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.25% during the next 3 months and, with a 90% probability hold a price between $34.72 and $50.87 at the end of this 3-month period.

MPLT Signals & Forecast

There are few to no technical positive signals at the moment. The Maplight Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $28.93. On a fall, the stock will find some support from the short-term average at $28.44. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 22, 2026, and so far it has fallen -10.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Maplight Therapeutics, Inc. stock

Maplight Therapeutics, Inc. finds support from accumulated volume at $28.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.74 between high and low, or 6.07%. For the last week, the stock has had daily average volatility of 8.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MPLT) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Maplight Therapeutics, Inc. to open at $29.30, and during the day (based on 14 day Average True Range), to move between $27.65 and $29.99, which gives a possible trading interval of +/-$2.34 (+/-8.47%) up or down from last closing price. If Maplight Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $29.11 (1.01%) than the support at $28.34 (1.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Maplight Therapeutics, Inc. stock A Buy?

The Maplight Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Maplight Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.895 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $29.30 ( 1.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MPLT Performance

Trading levels for MPLT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.04 7.70%
R2 30.38 5.40%
R1 29.96 3.97%
Price 28.82
S1 28.64 -0.641%
S2 28.22 -2.07%
S3 27.56 -4.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 32.13 11.49%
R2 29.41 2.05%
R1 29.11 1.01%
Price 28.82
S1 28.34 -1.67%
S2 28.01 -2.81%
S3 26.50 -8.05%

FAQ

What is the symbol for Maplight Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Maplight Therapeutics, Inc. is MPLT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Maplight Therapeutics, Inc. Stock?
The Maplight Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Maplight Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Maplight Therapeutics, Inc. Stock?
Maplight Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Maplight Therapeutics, Inc. Stock.

What's the current price of Maplight Therapeutics, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Maplight Therapeutics, Inc. (MPLT) share was $28.82.

What is the 52-week high and low for Maplight Therapeutics, Inc. Stock?
The 52-week high for Maplight Therapeutics, Inc. Stock is $33.28 and the 52-week low is $12.24.

What is the market capitalization of Maplight Therapeutics, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Maplight Therapeutics, Inc. is 22.749M.

When is the next earnings date for Maplight Therapeutics, Inc.?
The upcoming earnings date for Maplight Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE